Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Profit After Tax: 2021-2024

Historic Profit After Tax for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to -$188.3 million.

  • Abivax's Profit After Tax fell 173.24% to -$114.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$210.9 million, marking a year-over-year increase of 14.70%. This contributed to the annual value of -$188.3 million for FY2024, which is 18.48% down from last year.
  • According to the latest figures from FY2024, Abivax's Profit After Tax is -$188.3 million, which was down 18.48% from -$159.0 million recorded in FY2023.
  • In the past 5 years, Abivax's Profit After Tax registered a high of -$50.2 million during FY2021, and its lowest value of -$188.3 million during FY2024.
  • For the 3-year period, Abivax's Profit After Tax averaged around -$137.1 million, with its median value being -$159.0 million (2023).
  • Data for Abivax's Profit After Tax shows a maximum YoY slumped of 148.31% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Abivax's Profit After Tax stood at -$50.2 million in 2021, then dropped by 27.43% to -$64.0 million in 2022, then tumbled by 148.31% to -$159.0 million in 2023, then fell by 18.48% to -$188.3 million in 2024.